Aplasia medular adquirida y embarazo.
Caso clínico
Author
dc.contributor.author
León, Pilar
Author
dc.contributor.author
Leria, Josefina
Author
dc.contributor.author
Cardemil, Daniela
Author
dc.contributor.author
Díaz, Angélica
Author
dc.contributor.author
Hernández, Miguelina
Author
dc.contributor.author
Chubretovic, Magdalena
Author
dc.contributor.author
González, Josefa
Author
dc.contributor.author
Cabrera, María Elena
Admission date
dc.date.accessioned
2018-10-24T18:53:29Z
Available date
dc.date.available
2018-10-24T18:53:29Z
Publication date
dc.date.issued
2018
Cita de ítem
dc.identifier.citation
Rev Med Chile 2018; 146: 399-402
es_ES
Identifier
dc.identifier.other
10.4067/s0034-98872018000300399
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/152224
Abstract
dc.description.abstract
Aplastic anemia (AA) or acquired aplastic anemia is an uncommon and potentially fatal disease. It is defined as reduction of at least two peripheral blood series, associated with persistent bone marrow hypocellularity. It's association with pregnancy is even more uncommon, and it may result in high mortality for the mother and the child. We report an adolescent female with aplastic anemia, which worsened during pregnancy. Her hemoglobin was 5.2 g/dl, her leukocytes were 1,833/ul and her platelets were 19,000/ul. She was initially treated with cyclosporine and horse antithymocyte globulin without hematologic improvement. At 36 weeks of pregnancy methylprednisolone and platelet transfusions were used and a cesarean section was performed. Six month later she continues to require red blood cell and platelet transfusions.